Results 101 to 110 of about 14,162,596 (158)

Driver Gene Mutations Reprogram Lipid Metabolism in Non-Small Cell Lung Cancer. [PDF]

Cancer Med
Lin J, Pang Z, Jiang Z, Li F.
europepmc   +1 more source

A Chronobiological Prognostic Model for Resected Stage I Non-Small-Cell Lung Cancer. [PDF]

Cancers (Basel)
Leuzzi G, Minicozzi P, Verderio P, Ciniselli CM, Ferrari M, Pardolesi A, Stanzi A, Brandolini J, Rolli L, Calderoni M, Uslenghi C, Pastorino U, Lo Russo G, Proto C, Prelaj A, Beninato T, Lorenzini D, Solli P.   +17 more
europepmc   +1 more source

Advances in Radiotherapy for Neoadjuvant Therapy of Stage III Non-Small Cell Lung Cancer. [PDF]

Cancer Sci
Mao Q, Yu Y, Fang Y, Zhu S, Tang C, Cai J.   +5 more
europepmc   +1 more source

Myeloperoxidase promotes a tumorigenic microenvironment in non-small cell lung cancer. [PDF]

Redox Biol
Valadez-Cosmes P, Maitz K, Lagler A, Kindler O, Mujkanovic NC, Raftopoulou S, Kienzl M, Juvan ZN, Santiso A, Brcic L, Gorkiewicz G, Lindenmann J, Sattler W, Heinemann A, Schicho R, Marsche G, Houghton AM, Kargl J.   +17 more
europepmc   +1 more source

The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review. [PDF]

Explor Target Antitumor Ther
Moghrabi S, Ruzzeh S, Al-Rabi K, Abdlkadir A, Al-Jaghbeer MJ, Alzorgan N, Rasheed UA, Alqudah M, Al-Ibraheem A.   +8 more
europepmc   +1 more source

Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy. [PDF]

Mol Oncol
Nymoen HM, Zhao Z, Horndalsveen H, Bjaanæs MM, Grønberg BH, Halvorsen T, Madebo T, Aanerud M, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Alver TN, Dalen T, Öjlert ÅK, Farooqi SJ, Helland Å, Haakensen VD.   +19 more
europepmc   +1 more source

Advanced and underlying therapeutic strategies in transformed small cell lung cancer. [PDF]

Front Med (Lausanne)
Wei M, Li Z, Zhu K, Guo S, Hu L, Yang F, Chen X, Zhang X, Jiang S, Zhu X, Shen X.   +10 more
europepmc   +1 more source